National Register of patients with insulin pump treatment in the Czech Republic

Aims: The national register of patients treated with continuous subcutaneous insulin infusion (CSII) exists in the Czech Republic since 1998. The aim of this report is to present data on current situation and treatment results of CSII on wide unselected population.Methods: At present, we gather data from 52 departments of diabetology in the Czech Republic from patients with diabetes of all types treated with CSII. The data are collected continuously utilizing a special database program or by means of questionnaires.Results: We register data of 2060 patients treated with CSII to the end of 2005. Patients with type 1 diabetes represent 88.5%, type 2 8.5%, other 3%, men 47.7%, women 52.3%. The average age is 39.74±3.98 years, the duration of the CSII treatment is 4.56 ± 3.34 years. The insulin pump treatment leads to statistically significant improvement of glycemic control – HbA1c before CSII 9.60 ± 2.083% vs. after first and second year of treatment 8.47 ± 1.840 and 8.38 ± 1.611% (p < 0.001) respectively. The same trend is observed in the total insulin dose.Conclusions: The Register is a unique national project that maximally objectively, long-lastingly and continually monitors patients treated with insulin pumps. Our results show an enduring character of the improvement of monitored parameters.